ArticleFrontiers in immunology2026

Sequential tislelizumab plus bronchial arterial chemoembolization and systemic chemotherapy in advanced NSCLC with bulky tumors: efficacy and safety.

Yaping Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.